PROCHLORPERAZINE MALEATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Prochlorperazine Maleate, and when can generic versions of Prochlorperazine Maleate launch?
Prochlorperazine Maleate is a drug marketed by Ajanta Pharma Ltd, Amneal, Bionpharma, Chartwell Rx, Duramed Pharms Barr, Glenmark Pharms Ltd, Ivax Sub Teva Pharms, Mylan, Novitium Pharma, Teva Pharms, and Zydus Lifesciences. and is included in fourteen NDAs.
The generic ingredient in PROCHLORPERAZINE MALEATE is prochlorperazine maleate. There are twenty-one drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the prochlorperazine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prochlorperazine Maleate
A generic version of PROCHLORPERAZINE MALEATE was approved as prochlorperazine maleate by NOVITIUM PHARMA on June 13th, 2022.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROCHLORPERAZINE MALEATE?
- What are the global sales for PROCHLORPERAZINE MALEATE?
- What is Average Wholesale Price for PROCHLORPERAZINE MALEATE?
Summary for PROCHLORPERAZINE MALEATE
![PROCHLORPERAZINE MALEATE drug patent expirations Drug patent expirations by year for PROCHLORPERAZINE MALEATE](/p/graph/s/t/PROCHLORPERAZINE_MALEATE-patent-expirations.png)
![Drug Prices for PROCHLORPERAZINE MALEATE](/p/graph/drug-price/PROCHLORPERAZINE+MALEATE.png)
See drug prices for PROCHLORPERAZINE MALEATE
![Drug Sales Revenue Trends for PROCHLORPERAZINE MALEATE](/p/graph/drug-sales-revenues/PROCHLORPERAZINE+MALEATE.png)
Pharmacology for PROCHLORPERAZINE MALEATE
Drug Class | Phenothiazine |